CAPSULE ARRAY DEVICES AND METHODS OF USE
First Claim
Patent Images
1. A method for processing a nucleic acid sample, comprising:
- (a) providing at least 1,000 oligonucleotide molecules coupled to a bead, wherein the at least 1,000 oligonucleotide molecules comprise barcode sequences, which barcode sequences are the same sequence for the at least 1,000 oligonucleotide molecules;
(b) combining the at least 1,000 oligonucleotide molecules and a cellular sample in a partition among a plurality of partitions, wherein the cellular sample comprises the nucleic acid sample; and
(c) in the partition, using the at least 1,000 oligonucleotide molecules to barcode the nucleic acid sample from the cellular sample, thereby providing a barcoded nucleic acid molecule derived from the nucleic acid sample in the partition and external to the cellular sample.
1 Assignment
0 Petitions
Accused Products
Abstract
This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For example, a device of this disclosure can achieve physical partitioning and discrete mixing of samples with unique molecular identifiers within a single unit in preparation for various analysis operations. The device may be useful in a variety of applications and most notably nucleic-acid-based sequencing, detection and quantification of gene expression and single-cell analysis.
140 Citations
25 Claims
-
1. A method for processing a nucleic acid sample, comprising:
-
(a) providing at least 1,000 oligonucleotide molecules coupled to a bead, wherein the at least 1,000 oligonucleotide molecules comprise barcode sequences, which barcode sequences are the same sequence for the at least 1,000 oligonucleotide molecules; (b) combining the at least 1,000 oligonucleotide molecules and a cellular sample in a partition among a plurality of partitions, wherein the cellular sample comprises the nucleic acid sample; and (c) in the partition, using the at least 1,000 oligonucleotide molecules to barcode the nucleic acid sample from the cellular sample, thereby providing a barcoded nucleic acid molecule derived from the nucleic acid sample in the partition and external to the cellular sample. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
Specification